Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2022

TCT 553: Six-fold Increased Mortality in STEMI Patients With COVID versus Without In a Large Hospital System in South Florida

Presenter: Mohammed Ebrahim

September 18, 2022

Presentation TCT 2022

TCT 551: The effect of the COVID-19 vaccines on individuals that develop incidences of non-traumatic intracranial hemorrhages

Presenter: Isabella Gharib

September 18, 2022

Presentation TCT 2022

TCT 550: In-hospital Versus Out-of-Hospital STEMI Mortality in COVID Negative Versus COVID Positive Patients in a Large Hospital System in South Florida

Presenter: Lindsey Clark

September 18, 2022

Presentation TCT 2022

TCT 549: Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry.

Presenter: Xavier Armario

September 18, 2022

Presentation ESC 2022

Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial

Presenter: John Eikelboom

August 29, 2022

Presentation ESC 2022

Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial

Presenter: Sanjit Jolly

August 28, 2022

Presentation ARCH 2022

Cardiovascular Complications of Covid-19: Direct and Indirect with Insights from NACMI

Presenter: Timothy D. Henry

April 23, 2022

Presentation SCAD 2022

Spectrum of Heart Disease in Women

Presenter: Roxana Mehran

February 19, 2022

Presentation SCAD 2022

How COVID-19 Has Affected Management of MI Patients

Presenter: Timothy Henry

February 19, 2022

Presentation Controversies and Advances 2021

Clinical Pearls for P.O.T.S.

Presenter: Peng-Sheng Chen

December 03, 2021

Presentation TCT 2021

Myocarditis After Covid-19 Vaccination: What Clinicians Need to Know

Presenter: Guy Witberg

November 04, 2021

Presentation TCT 2021

Impact of the COVID-19 Pandemic on FDA: Review of Changes and Looking Ahead

Presenter: William Maisel

November 04, 2021

Presentation ESC 2021

Medically Ill Hospitalized Patients For COVID –19 Thrombosis Extended Prophylaxis With Rivaroxaban Therapy: THE MICHELLE TRIAL

Presenter: Eduardo Ramacciotti

August 30, 2021

Presentation SCAD 2021

COVID-19 and STEMI with a SCAD perspective

Presenter: Timothy D. Henry

January 30, 2021

Advertisement

TCT 553: Six-fold Increased Mortality in STEMI Patients With COVID versus Without In a Large Hospital System in South Florida

TCT 551: The effect of the COVID-19 vaccines on individuals that develop incidences of non-traumatic intracranial hemorrhages

TCT 550: In-hospital Versus Out-of-Hospital STEMI Mortality in COVID Negative Versus COVID Positive Patients in a Large Hospital System in South Florida

TCT 549: Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry.

Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial

Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial

Cardiovascular Complications of Covid-19: Direct and Indirect with Insights from NACMI

Spectrum of Heart Disease in Women

How COVID-19 Has Affected Management of MI Patients

Clinical Pearls for P.O.T.S.

Myocarditis After Covid-19 Vaccination: What Clinicians Need to Know

Impact of the COVID-19 Pandemic on FDA: Review of Changes and Looking Ahead

Medically Ill Hospitalized Patients For COVID –19 Thrombosis Extended Prophylaxis With Rivaroxaban Therapy: THE MICHELLE TRIAL

COVID-19 and STEMI with a SCAD perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content